Metabolomics of alcoholic liver disease: A clinical discovery study

RSC Advances

Volumn 5, Issue 98, 2015, Pages 80381-80387

  Liang, Qun ^a   Wang, Cong ^a   Li, Binbing ^a   Zhang, Ai Hua ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; BIOMOLECULES; BODY FLUIDS; DISEASE CONTROL; METABOLITES;

BIO-MARKER DISCOVERY; EARLY DIAGNOSIS; EFFECTIVE THERAPY; LATE STAGE; LIVER DISEASE; LOW MOLECULAR WEIGHT; METABOLOMICS;

DIAGNOSIS;

EID: 84942284227     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c5ra13417j     Document Type: Article

References (20)

1. O. George C. Sanders J. Freiling E. Grigoryan S. Vu C. D. Allen E. Crawford C. D. Mandyam G. F. Koob Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking Proc. Natl. Acad. Sci. U. S. A. 2012 109 44 18156 18161
2. N. A. Nasrallah J. J. Clark A. L. Collins C. A. Akers P. E. Phillips I. L. Bernstein Risk preference following adolescent alcohol use is associated with corrupted encoding of costs but not rewards by mesolimbic dopamine Proc. Natl. Acad. Sci. U. S. A. 2011 108 13 5466 5471
3. S. F. Kendrick G. O'Boyle J. Mann M. Zeybel J. Palmer D. E. Jones C. P. Day Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis Hepatology 2010 51 6 1988 1997
4. R. P. Mookerjee M. Malaki N. A. Davies S. J. Hodges R. N. Dalton C. Turner S. Sen R. Williams J. Leiper P. Vallance R. Jalan Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis Hepatology 2007 45 1 62 71
5. W. R. Kim J. B. Gross Jr J. J. Poterucha G. R. Locke 3rd E. R. Dickson Outcome of hospital care of liver disease associated with hepatitis C in the United States Hepatology 2001 33 1 201 206
6. A. Sreekumar L. M. Poisson T. M. Rajendiran A. P. Khan Q. Cao J. Yu B. Laxman R. Mehra R. J. Lonigro Y. Li M. K. Nyati A. Ahsan S. Kalyana-Sundaram B. Han X. Cao J. Byun G. S. Omenn D. Ghosh S. Pennathur D. C. Alexander A. Berger J. R. Shuster J. T. Wei S. Varambally C. Beecher A. M. Chinnaiyan Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009 457 910 914
7. K. Suhre S. Y. Shin A. K. Petersen R. P. Mohney D. Meredith B. Wägele E. Altmaier D. P. CARDIoGRAM J. Erdmann E. Grundberg C. J. Hammond M. H. de Angelis G. Kastenmüller A. Köttgen F. Kronenberg M. Mangino C. Meisinger T. Meitinger H. W. Mewes M. V. Milburn C. Prehn J. Raffler J. S. Ried W. Römisch-Margl N. J. Samani K. S. Small H. E. Wichmann G. Zhai T. Illig T. D. Spector J. Adamski N. Soranzo C. Gieger T. L. Assimes P. Deloukas J. Erdmann H. Holm S. Kathiresan I. R. König R. McPherson M. P. Reilly R. Roberts N. J. Samani H. Schunkert A. F. Stewart Human metabolic individuality in biomedical and pharmaceutical research Nature 2011 477 54 60
8. Q. Liang C. Wang B. Li A. H. Zhang Metabolic fingerprinting to understand therapeutic effects and mechanisms of silybin on acute liver damage in rat Pharmacogn. Mag. 2015 11 43 586 593
9. A. K. Arakaki J. Skolnick J. F. McDonald Marker metabolites can be therapeutic targets as well Nature 2008 456 7221 443
10. T. J. Wang M. G. Larson R. S. Vasan S. Cheng E. P. Rhee E. McCabe G. D. Lewis C. S. Fox P. F. Jacques C. Fernandez C. J. O'Donnell S. A. Carr V. K. Mootha J. C. Florez A. Souza O. Melander C. B. Clish R. E. Gerszten Metabolite profiles and the risk of developing diabetes Nat. Med. 2011 17 4 448 453
11. G. J. Patti O. Yanes L. P. Shriver J. P. Courade R. Tautenhahn M. Manchester G. Siuzdak Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin Nat. Chem. Biol. 2012 8 3 232 234
12. M. Tomita K. Kami Cancer. Systems biology, metabolomics, and cancer metabolism Science 2012 336 6084 990 991
13. J. P. Ioannidis M. J. Khoury Improving validation practices in omics research Science 2011 334 6060 1230 1232
14. Q. Liang C. Wang B. Li Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer Appl. Biochem. Biotechnol. 2015 176 8 2170 2184
15. M. Mapstone A. K. Cheema M. S. Fiandaca X. Zhong T. R. Mhyre L. H. Macarthur W. J. Hall S. G. Fisher D. R. Peterson J. M. Haley M. D. Nazar S. A. Rich D. J. Berlau C. B. Peltz M. T. Tan C. H. Kawas H. J. Federoff Plasma phospholipids identify antecedent memory impairment in older adults Nat. Med. 2014 20 4 415 418
16. S. K. Manna A. D. Patterson Q. Yang K. W. Krausz J. R. Idle A. J. Fornace F. J. Gonzalez UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model J. Proteome Res. 2011 10 9 4120 4133
17. A. H. Zhang H. Sun Y. Han G. L. Yan Y. Yuan G. C. Song X. X. Yuan N. Xie X. J. Wang Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets Anal. Chem. 2013 85 15 7606 7612
18. K. T. Kotz W. Xiao C. Miller-Graziano W. J. Qian A. Russom E. A. Warner L. L. Moldawer A. de P. E. Bankey B. O. Petritis D. G. Camp 2nd A. E. Rosenbach J. Goverman S. P. Fagan B. H. Brownstein D. Irimia W. Xu J. Wilhelmy M. N. Mindrinos R. D. Smith R. W. Davis R. G. Tompkins M. Toner Inflammation and the Host Response to Injury Collaborative Research Program. Clinical microfluidics for neutrophil genomics and proteomics Nat. Med. 2010 16 9 1042 1047
19. A. Zhang H. Sun Y. Han G. Yan X. Wang Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system PLoS One 2013 8 5 e64381
20. T. J. Wang M. G. Larson R. S. Vasan S. Cheng E. P. Rhee E. McCabe G. D. Lewis C. S. Fox P. F. Jacques C. Fernandez C. J. O'Donnell S. A. Carr V. K. Mootha J. C. Florez A. Souza O. Melander C. B. Clish R. E. Gerszten Metabolite profiles and the risk of developing diabetes Nat. Med. 2011 17 4 448 453